These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses. Brentville VA, Metheringham RL, Daniels I, Atabani S, Symonds P, Cook KW, Vankemmelbeke M, Choudhury R, Vaghela P, Gijon M, Meiners G, Krebber WJ, Melief CJM, Durrant LG. J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32561639 [Abstract] [Full Text] [Related]
3. Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy. Brentville VA, Symonds P, Chua J, Skinner A, Daniels I, Cook KW, Koncarevic S, Martinez-Pinna R, Shah S, Choudhury RH, Vaghela P, Weston D, Al-Omari A, Davis J, Durrant LG. Front Immunol; 2022 Jun; 13():1066185. PubMed ID: 36544781 [Abstract] [Full Text] [Related]
4. Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool. Choudhury RH, Daniels I, Vaghela P, Atabani S, Kirk T, Symonds P, Cook KW, Al-Omari A, Weston D, Shah S, Hutchinson D, Paston SJ, Metheringham RL, Brentville VA, Durrant LG. Immunology; 2023 Aug; 169(4):467-486. PubMed ID: 37055914 [Abstract] [Full Text] [Related]
5. Post-translational modifications such as citrullination are excellent targets for cancer therapy. Brentville VA, Vankemmelbeke M, Metheringham RL, Durrant LG. Semin Immunol; 2020 Feb; 47():101393. PubMed ID: 31932199 [Abstract] [Full Text] [Related]
6. Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses. Symonds P, Marcu A, Cook KW, Metheringham RL, Durrant LG, Brentville VA. Front Immunol; 2021 Feb; 12():764462. PubMed ID: 34858415 [Abstract] [Full Text] [Related]
7. Citrullinated α-enolase is an effective target for anti-cancer immunity. Cook K, Daniels I, Symonds P, Pitt T, Gijon M, Xue W, Metheringham R, Durrant L, Brentville V. Oncoimmunology; 2018 Feb; 7(2):e1390642. PubMed ID: 29308319 [Abstract] [Full Text] [Related]
8. T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy. Brentville VA, Symonds P, Cook KW, Daniels I, Pitt T, Gijon M, Vaghela P, Xue W, Shah S, Metheringham RL, Durrant LG. Oncoimmunology; 2019 Feb; 8(5):e1576490. PubMed ID: 31069134 [Abstract] [Full Text] [Related]
9. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers. Wang Y, Chen R, Gan Y, Ying S. Int J Cancer; 2021 Jan 15; 148(2):267-276. PubMed ID: 33459350 [Abstract] [Full Text] [Related]
10. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage. Romero V, Darrah E, Andrade F. Arthritis Rheumatol; 2020 Jun 15; 72(6):912-918. PubMed ID: 31876120 [Abstract] [Full Text] [Related]
11. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation. Bawadekar M, Shim D, Johnson CJ, Warner TF, Rebernick R, Damgaard D, Nielsen CH, Pruijn GJM, Nett JE, Shelef MA. J Autoimmun; 2017 Jun 15; 80():39-47. PubMed ID: 28188029 [Abstract] [Full Text] [Related]
12. Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy. Cook KW, Xue W, Symonds P, Daniels I, Gijon M, Boocock D, Coveney C, Miles AK, Shah S, Atabani S, Choudhury RH, Vaghela P, Weston D, Metheringham RL, Brentville VA, Durrant LG. J Immunother Cancer; 2021 Jul 15; 9(7):. PubMed ID: 34321274 [Abstract] [Full Text] [Related]
13. Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination. Sun B, Chang HH, Salinger A, Tomita B, Bawadekar M, Holmes CL, Shelef MA, Weerapana E, Thompson PR, Ho IC. JCI Insight; 2019 Nov 14; 4(22):. PubMed ID: 31723060 [Abstract] [Full Text] [Related]
14. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure. Damiana T, Damgaard D, Sidelmann JJ, Nielsen CH, de Maat MPM, Münster AB, Palarasah Y. Clin Chim Acta; 2020 Feb 14; 501():6-11. PubMed ID: 31730822 [Abstract] [Full Text] [Related]
15. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis. Darrah E, Davis RL, Curran AM, Naik P, Chen R, Na CH, Giles JT, Andrade F. Arthritis Rheumatol; 2020 Sep 14; 72(9):1476-1482. PubMed ID: 32255561 [Abstract] [Full Text] [Related]
16. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4. Martín Monreal MT, Rebak AS, Massarenti L, Mondal S, Šenolt L, Ødum N, Nielsen ML, Thompson PR, Nielsen CH, Damgaard D. Front Immunol; 2021 Sep 14; 12():716250. PubMed ID: 34737738 [Abstract] [Full Text] [Related]
17. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases. Holmes CL, Shim D, Kernien J, Johnson CJ, Nett JE, Shelef MA. J Immunol Res; 2019 Sep 14; 2019():2160192. PubMed ID: 30993117 [Abstract] [Full Text] [Related]